Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB), 61292-61293 [05-21101]

Download as PDF 61292 Federal Register / Vol. 70, No. 203 / Friday, October 21, 2005 / Notices approved collection; Title of Information Collection: Request for Retirement Benefit Information (BBA ‘97); Form Number: CMS–R–285 (OMB#: 0938–0769); Use: The Request for Retirement Benefit Information form is used to obtain retirement benefit information from beneficiaries that purchase Medicare Part A coverage. The Social Security Administration (SSA) will use this information to determine if a beneficiary meets the requirements to qualify for a Medicare Part A premium reduction.; Frequency: Reporting—On occasion; Affected Public: State, Local or Tribal Government; Number of Respondents: 1500; Total Annual Responses: 1500; Total Annual Hours: 375. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS’l Web site address at https://www.cms.hhs.gov/ regulations/pra/, or E-mail your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786–1326. To be assured consideration, comments and recommendations for the proposed information collections must be received at the address below, no later than 5 p.m. on December 20, 2005. CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Bonnie L Harkless, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. Dated: October 13, 2005. Michelle Shortt, Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 05–20962 Filed 10–20–05; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare and Medicaid Services [Document Identifier: CMS–10133] Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB) Center for Medicare and Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid AGENCY: VerDate Aug<31>2005 15:13 Oct 20, 2005 Jkt 208001 Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. We are, however, requesting an emergency review of the information collection referenced below. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have submitted to the Office of Management and Budget (OMB) the following requirements for emergency review. We are requesting an emergency review because the collection of this information is needed before the expiration of the normal time limits under OMB’s regulations at 5 CFR Part 1320. This is necessary to ensure compliance with an initiative of the Administration. We cannot reasonably comply with the normal clearance procedures because the use of normal clearance procedures will jeopardize program implementation by a statutorily mandated deadline and could contribute to impaired beneficiary access to Part B drugs. Section 303(d) of the MMA provides an alternative payment methodology for Part B drugs that are not paid on a cost or prospective payment basis. In particular, Section 303(d) of the MMA amends Title XVIII of the Social Security Act (the Act) by adding a new section 1847B, which establishes a competitive acquisition program for the acquisition of and payment for Part B covered drugs and biologicals furnished on or after January 1, 2006. Beginning in 2006, physicians will have a choice between acquiring and billing for Part B covered drugs under the Average Sales Price (ASP) drug payment methodology or electing to receive these drugs from vendors/suppliers selected for the Competitive Acquisition Program (CAP), through a competitive bidding process. The provisions for this new payment system are described in the proposed rule (42 CFR Part 414 Subpart K) published March 4, 2005 (70 FR 10746), the interim final rule published July 6, PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 2005 (70 FR 39022), and a final rule that is expected to be published in November 2005. 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Competitive Acquisition Program for Medicare Part B Drugs: Vendor Application and Bid Form; Use: The CAP Vendor Application and Bid Form is a collection tool which will be used by potential vendors to provide information related to the characteristics of their company and to submit their bid prices for CAP drugs. The information collected on the CAP Vendor Application and Bid Form will be used by CMS during the bidding evaluation process to evaluate the vendors bid prices, their credentials, experience and to assess their ability to provide quality service to physicians and beneficiaries. Competitive bidding is seen as a means of using the dynamics of the marketplace to provide incentives for suppliers to provide reasonably priced products and services of high quality in an efficient manner. The CAP’s objectives include providing an alternative method for physicians to obtain Part B drugs to administer to Medicare beneficiaries and reducing drug acquisition and billing burdens for physicians; Form Number: CMS–10133 (OMB#: 0938–0955); Frequency: Reporting—Other, during enrollment; Affected Public: Business or other forprofit; Number of Respondents: 12; Total Annual Responses: 12; Total Annual Hours: 480. CMS is requesting OMB review and approval of this collection by November 1, 2005, with a 180-day approval period. Written comments and recommendations will be considered from the public if received by the individuals designated below by October 28, 2005. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access the CMS Web site address at https://www.cms.hhs.gov/ regulations/pra or e-mail your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786–1326. Interested persons are invited to send comments regarding the burden or any other aspect of these collections of information requirements. However, as noted above, comments on these information collection and recordkeeping requirements must be mailed to the designees referenced below by October 28, 2005: E:\FR\FM\21OCN1.SGM 21OCN1 Federal Register / Vol. 70, No. 203 / Friday, October 21, 2005 / Notices Centers for Medicare and Medicaid Services, Office of Strategic Operations and Regulatory Affairs, Room C4–26–05, 7500 Security Boulevard, Baltimore, MD 21244–1850, Fax Number: (410) 786– 5267, Attn: William N. Parham, III and, OMB Human Resources and Housing Branch, Attention: CMS Desk Officer, New Executive Office Building, Room 10235, Washington, DC 20503. Dated: October 17, 2005. Michelle Shortt, Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 05–21101 Filed 10–20–05; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Science Board to the Food and Drug Administration; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Science Board to FDA. General Function of the Committee: The Board shall provide advice primarily to the agency’s Senior Science Advisor and, as needed, to the Commissioner of Food and Drugs and other appropriate officials on specific complex and technical issues as well as emerging issues within the scientific community in industry and academia. Additionally, the Board will provide advice to the agency on keeping pace with technical and scientific evolutions in the fields of regulatory science, on formulating an appropriate research agenda, and on upgrading its scientific and research facilities to keep pace with these changes. It will also provide the means for critical review of agencysponsored intramural and extramural scientific research programs. Date and Time: The meeting will be held on November 4, 2005, from 8:30 a.m. to 4 p.m. Location: Washington Room, Holiday Inn Bethesda, 8120 Wisconsin Ave., Bethesda, MD. Contact Person: Jan Johannessen, Office of the Commissioner (HF–33), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–6687, jjohannessen@fda.gov, VerDate Aug<31>2005 15:13 Oct 20, 2005 Jkt 208001 or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512603. Please call the Information Line for up-to-date information on this meeting. Agenda: The Science Board will hear about and discuss the following topics: (1) An update on activities of the Drug Safety Oversight Board, (2) the agency’s Bioresearch Monitoring Initiative, and (3) the Board’s science peer review activities, including presentation of the Board’s peer review of the Office of Regulatory Affairs’ pesticide monitoring program. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by October 28, 2005. Oral presentations from the public will be scheduled between approximately 12:30 p.m. and 1:30 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before October 28, 2005, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Jan Johannessen at least 7 days in advance of the meeting. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: October 14, 2005. Jason Brodsky, Acting Associate Commissioner for External Relations. [FR Doc. 05–21036 Filed 10–20–05; 8:45 am] BILLING CODE 4160–01–S PO 00000 61293 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Statement of Organization, Functions and Delegations of Authority This notice amends Part R of the Statement of Organization Functions and Delegations of Authority of the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) as amended at (60 FR 56605, November 6, 1995; amended at 67 FR 46519, July 15, 2002; 68 FR 787–793, January 7, 2003, and 68 FR 64357–64358, November 13, 2003; and last amended at 69 FR 56433– 56434, September 21, 2004). This notice reflects changes to the organization and functions of the Office of Communications (RA6) and the Office of Information Technology (RAG) both in the Office of the Administrator (RA): Specifically, it moves the Audio Visual technology support function from the Office of Information Technology to the Office of Communications. Chapter RA—Office of the Administrator Section RA–10, Organization The Office of the Administrator (OA) is headed by the Administrator, Health Resources and Services Administration, who reports directly to the Secretary. The OA includes the following components: (1) Immediate Office of the Administrator (RA); (2) Office of Equal Opportunity and Civil Rights (RA2); (3) Office of Planning and Evaluation (RA5); (4) Office of Communications (RA6); (5) Office of Minority Health and Health Disparities (RA9); (6) Office of Legislation (RAE); (7) Office of International Health Affairs (RAH); and (8) Office of Information Technology (RAG). Section RA–20, Functions Delete the functional statements for the Office of Communications (RA6) and the Office of Information Technology (RAG) in their entirety and replace it with the following: Office of Communication (RA6) Provides leadership and general policy and program direction for, and conducts and coordinates communications and public affairs activities of the Agency; Specifically, (1) Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1

Agencies

[Federal Register Volume 70, Number 203 (Friday, October 21, 2005)]
[Notices]
[Pages 61292-61293]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-21101]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare and Medicaid Services

[Document Identifier: CMS-10133]


Emergency Clearance: Public Information Collection Requirements 
Submitted to the Office of Management and Budget (OMB)

AGENCY: Center for Medicare and Medicaid Services.

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid 
Services (CMS), Department of Health and Human Services, is publishing 
the following summary of proposed collections for public comment. 
Interested persons are invited to send comments regarding this burden 
estimate or any other aspect of this collection of information, 
including any of the following subjects: (1) The necessity and utility 
of the proposed information collection for the proper performance of 
the agency's functions; (2) the accuracy of the estimated burden; (3) 
ways to enhance the quality, utility, and clarity of the information to 
be collected; and (4) the use of automated collection techniques or 
other forms of information technology to minimize the information 
collection burden.
    We are, however, requesting an emergency review of the information 
collection referenced below. In compliance with the requirement of 
section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have 
submitted to the Office of Management and Budget (OMB) the following 
requirements for emergency review. We are requesting an emergency 
review because the collection of this information is needed before the 
expiration of the normal time limits under OMB's regulations at 5 CFR 
Part 1320. This is necessary to ensure compliance with an initiative of 
the Administration. We cannot reasonably comply with the normal 
clearance procedures because the use of normal clearance procedures 
will jeopardize program implementation by a statutorily mandated 
deadline and could contribute to impaired beneficiary access to Part B 
drugs.
    Section 303(d) of the MMA provides an alternative payment 
methodology for Part B drugs that are not paid on a cost or prospective 
payment basis. In particular, Section 303(d) of the MMA amends Title 
XVIII of the Social Security Act (the Act) by adding a new section 
1847B, which establishes a competitive acquisition program for the 
acquisition of and payment for Part B covered drugs and biologicals 
furnished on or after January 1, 2006. Beginning in 2006, physicians 
will have a choice between acquiring and billing for Part B covered 
drugs under the Average Sales Price (ASP) drug payment methodology or 
electing to receive these drugs from vendors/suppliers selected for the 
Competitive Acquisition Program (CAP), through a competitive bidding 
process. The provisions for this new payment system are described in 
the proposed rule (42 CFR Part 414 Subpart K) published March 4, 2005 
(70 FR 10746), the interim final rule published July 6, 2005 (70 FR 
39022), and a final rule that is expected to be published in November 
2005.
    1. Type of Information Collection Request: Extension of a currently 
approved collection; Title of Information Collection: Competitive 
Acquisition Program for Medicare Part B Drugs: Vendor Application and 
Bid Form; Use: The CAP Vendor Application and Bid Form is a collection 
tool which will be used by potential vendors to provide information 
related to the characteristics of their company and to submit their bid 
prices for CAP drugs. The information collected on the CAP Vendor 
Application and Bid Form will be used by CMS during the bidding 
evaluation process to evaluate the vendors bid prices, their 
credentials, experience and to assess their ability to provide quality 
service to physicians and beneficiaries. Competitive bidding is seen as 
a means of using the dynamics of the marketplace to provide incentives 
for suppliers to provide reasonably priced products and services of 
high quality in an efficient manner. The CAP's objectives include 
providing an alternative method for physicians to obtain Part B drugs 
to administer to Medicare beneficiaries and reducing drug acquisition 
and billing burdens for physicians; Form Number: CMS-10133 
(OMB: 0938-0955); Frequency: Reporting--Other, during 
enrollment; Affected Public: Business or other for-profit; Number of 
Respondents: 12; Total Annual Responses: 12; Total Annual Hours: 480.
    CMS is requesting OMB review and approval of this collection by 
November 1, 2005, with a 180-day approval period. Written comments and 
recommendations will be considered from the public if received by the 
individuals designated below by October 28, 2005.
    To obtain copies of the supporting statement and any related forms 
for the proposed paperwork collections referenced above, access the CMS 
Web site address at https://www.cms.hhs.gov/regulations/pra or e-mail 
your request, including your address, phone number, OMB number, and CMS 
document identifier, to Paperwork@cms.hhs.gov, or call the Reports 
Clearance Office on (410) 786-1326.
    Interested persons are invited to send comments regarding the 
burden or any other aspect of these collections of information 
requirements. However, as noted above, comments on these information 
collection and recordkeeping requirements must be mailed to the 
designees referenced below by October 28, 2005:

[[Page 61293]]

    Centers for Medicare and Medicaid Services, Office of Strategic 
Operations and Regulatory Affairs, Room C4-26-05, 7500 Security 
Boulevard, Baltimore, MD 21244-1850, Fax Number: (410) 786-5267, Attn: 
William N. Parham, III and, OMB Human Resources and Housing Branch, 
Attention: CMS Desk Officer, New Executive Office Building, Room 10235, 
Washington, DC 20503.

    Dated: October 17, 2005.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations 
and Regulatory Affairs.
[FR Doc. 05-21101 Filed 10-20-05; 8:45 am]
BILLING CODE 4120-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.